About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 568 entries already.
Entries by Max
Newsletter 22/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! Summer is approaching (ok, apologies to our friends from down under), but research doesn’t stop! Once again this week, we’ve got major updates on clinical trials—and just one preclinical study, but it’s been carefully selected just for you! Stay […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- KLS-3021 An Oncolytic Viral Therapy For Prostate Cancer Could Soon Reach Clinical Trial Stage February 9, 2026
- Newsletter 6/2026 February 8, 2026
- SPR1020: a Promising PARP1-Selective Inhibitor in Advanced Solid Tumors (Including mCRPC) February 6, 2026
- Dual-Action Nanomaterial Eradicates Cancer Cells And Spares Healthy Tissue February 6, 2026
